InMode Ltd.

INMD Healthcare Medical Devices

InMode Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $370.5 million, down 6.16% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 31.0% and free cash flow fell 12.6%, each against the same quarter a year earlier.

14.16 0.16 −1.12%
Market cap
$824.0M
P/E
11.3×
Fwd P/E
11.8×
Dividend yield
—
F-score
4/9
Altman Z
10.45
Beneish M
−2.25
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

5 4 6 6
ROE
0.00% 13.91% 0.00% 0.00%
ROA
19.68% 12.09% 11.98% 10.85%
ROIC
45.04% 41.74% 40.20% 33.78%
Return on Tangible Assets
24.92% 14.88% 14.39% 13.52%
Average Days of Receivables
62.67 68.21 70.35 75.24
Free Cash Flow per Share
1.49 1.30 1.35 1.40
Free Cash Flow
94.35 84.29 85.54 82.53
Capital Expenditures
(0.67) (0.97) (1.06) (1.05)
Other line items
Cash ROIC
7.96% 6.81% 7.14% 7.30%
Accounts Receivable Turnover
6.02 5.80 5.76 5.46
Accounts Payable Turnover
5.06 5.02 5.20 4.85
Inventory Turnover
1.18 1.19 1.23 1.26
Average Days of Payables
79.08 82.21 74.09 77.99
Days of Inventory on Hand
337.65 339.87 313.92 297.41
Tax Rate
0.34 (0.15) (0.15) (0.15)
Research and Development Expense of Revenue
3.42% 3.59% 3.73% 3.80%
Selling, General and Administrative Expense of Revenue
51.46% 51.89% 52.80% 54.25%
Share Based Compensation of Revenue
3.31% 3.00% 3.02% 3.10%
Operating CF/Net income
0.64 0.91 0.99 1.08
Depreciation/Fixed assets
0.34 0.27 0.27 0.26
Capex/Depreciation
(0.87) (1.40) (1.52) (1.54)
Revenue per Share
5.76 5.73 5.91 6.36
Operating CF per Share
1.50 1.32 1.37 1.42
Capex per Share
(0.01) (0.01) (0.02) (0.02)
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates